| Pascal Atanga, MD | |
|
1710 Harper Rd, Beckley, WV 25801-3397 | |
| (304) 461-3922 | |
| (304) 254-6016 |
| Full Name | Pascal Atanga |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 12 Years |
| Location | 1710 Harper Rd, Beckley, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700267770 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 25891 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Raleigh General Hospital | Beckley, WV | Hospital |
| Thomas Memorial Hospital | South charleston, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Raleigh General Hospital Llc | 6103735154 | 29 |
| Ths Physician Partners Inc | 9537316393 | 135 |
News Archive
Analysis of the CANTO cohort published in the journal Annals of Oncology will upset received wisdom on the effects that hormone therapy and chemotherapy have on the quality of life in women with breast cancer. Contrary to the commonly held view, 2 years after diagnosis, hormone therapy, a highly effective breast cancer treatment worsens quality of life to a greater extent and for a longer time, especially in menopausal patients.
Difficult to treat and aggressive "triple-negative" breast cancer is chemoresistant even before chemotherapy begins, a new study by researchers from Karolinska Institutet and the University of Texas MD Anderson Cancer Center reports. The findings, which are published in the journal Cell, may lead to better and more personalized treatments for breast cancer.
Researchers from Columbia University Medical Center, NewYork-Presbyterian, the Pediatric Cardiac Genetics Consortium, and the Pediatric Heart Network have found a number of genetic mutations that explain why many children with congenital heart disease also have other significant health challenges, including neurodevelopmental disorders and other congenital problems.
The AMA is co-sponsoring a symposium for CME credit this month in Tampa, Fla., on the medical and public health aspects of mercury exposure. "Mercury: Medical and Public Health Issues" will be held from April 28-30 at the Tampa Marriott Waterside Hotel and Marina.
Patients with the most common type of lung cancer are notoriously insensitive to chemotherapy drugs, including cisplatin. New findings related to the cellular pathways that regulate responses to cisplatin have now been published by Cell Press on July 26th in the journal Cell Reports.
› Verified 3 days ago
| Entity Name | West Virginia University Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275504508 PECOS PAC ID: 1052224565 Enrollment ID: O20031111000207 |
News Archive
Analysis of the CANTO cohort published in the journal Annals of Oncology will upset received wisdom on the effects that hormone therapy and chemotherapy have on the quality of life in women with breast cancer. Contrary to the commonly held view, 2 years after diagnosis, hormone therapy, a highly effective breast cancer treatment worsens quality of life to a greater extent and for a longer time, especially in menopausal patients.
Difficult to treat and aggressive "triple-negative" breast cancer is chemoresistant even before chemotherapy begins, a new study by researchers from Karolinska Institutet and the University of Texas MD Anderson Cancer Center reports. The findings, which are published in the journal Cell, may lead to better and more personalized treatments for breast cancer.
Researchers from Columbia University Medical Center, NewYork-Presbyterian, the Pediatric Cardiac Genetics Consortium, and the Pediatric Heart Network have found a number of genetic mutations that explain why many children with congenital heart disease also have other significant health challenges, including neurodevelopmental disorders and other congenital problems.
The AMA is co-sponsoring a symposium for CME credit this month in Tampa, Fla., on the medical and public health aspects of mercury exposure. "Mercury: Medical and Public Health Issues" will be held from April 28-30 at the Tampa Marriott Waterside Hotel and Marina.
Patients with the most common type of lung cancer are notoriously insensitive to chemotherapy drugs, including cisplatin. New findings related to the cellular pathways that regulate responses to cisplatin have now been published by Cell Press on July 26th in the journal Cell Reports.
› Verified 3 days ago
| Entity Name | Raleigh General Hospital Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114475746 PECOS PAC ID: 6103735154 Enrollment ID: O20040914001132 |
News Archive
Analysis of the CANTO cohort published in the journal Annals of Oncology will upset received wisdom on the effects that hormone therapy and chemotherapy have on the quality of life in women with breast cancer. Contrary to the commonly held view, 2 years after diagnosis, hormone therapy, a highly effective breast cancer treatment worsens quality of life to a greater extent and for a longer time, especially in menopausal patients.
Difficult to treat and aggressive "triple-negative" breast cancer is chemoresistant even before chemotherapy begins, a new study by researchers from Karolinska Institutet and the University of Texas MD Anderson Cancer Center reports. The findings, which are published in the journal Cell, may lead to better and more personalized treatments for breast cancer.
Researchers from Columbia University Medical Center, NewYork-Presbyterian, the Pediatric Cardiac Genetics Consortium, and the Pediatric Heart Network have found a number of genetic mutations that explain why many children with congenital heart disease also have other significant health challenges, including neurodevelopmental disorders and other congenital problems.
The AMA is co-sponsoring a symposium for CME credit this month in Tampa, Fla., on the medical and public health aspects of mercury exposure. "Mercury: Medical and Public Health Issues" will be held from April 28-30 at the Tampa Marriott Waterside Hotel and Marina.
Patients with the most common type of lung cancer are notoriously insensitive to chemotherapy drugs, including cisplatin. New findings related to the cellular pathways that regulate responses to cisplatin have now been published by Cell Press on July 26th in the journal Cell Reports.
› Verified 3 days ago
| Entity Name | Ths Physician Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871866806 PECOS PAC ID: 9537316393 Enrollment ID: O20120829000738 |
News Archive
Analysis of the CANTO cohort published in the journal Annals of Oncology will upset received wisdom on the effects that hormone therapy and chemotherapy have on the quality of life in women with breast cancer. Contrary to the commonly held view, 2 years after diagnosis, hormone therapy, a highly effective breast cancer treatment worsens quality of life to a greater extent and for a longer time, especially in menopausal patients.
Difficult to treat and aggressive "triple-negative" breast cancer is chemoresistant even before chemotherapy begins, a new study by researchers from Karolinska Institutet and the University of Texas MD Anderson Cancer Center reports. The findings, which are published in the journal Cell, may lead to better and more personalized treatments for breast cancer.
Researchers from Columbia University Medical Center, NewYork-Presbyterian, the Pediatric Cardiac Genetics Consortium, and the Pediatric Heart Network have found a number of genetic mutations that explain why many children with congenital heart disease also have other significant health challenges, including neurodevelopmental disorders and other congenital problems.
The AMA is co-sponsoring a symposium for CME credit this month in Tampa, Fla., on the medical and public health aspects of mercury exposure. "Mercury: Medical and Public Health Issues" will be held from April 28-30 at the Tampa Marriott Waterside Hotel and Marina.
Patients with the most common type of lung cancer are notoriously insensitive to chemotherapy drugs, including cisplatin. New findings related to the cellular pathways that regulate responses to cisplatin have now been published by Cell Press on July 26th in the journal Cell Reports.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pascal Atanga, MD 1710 Harper Rd, Beckley, WV 25801-3397 Ph: (304) 461-3922 | Pascal Atanga, MD 1710 Harper Rd, Beckley, WV 25801-3397 Ph: (304) 461-3922 |
News Archive
Analysis of the CANTO cohort published in the journal Annals of Oncology will upset received wisdom on the effects that hormone therapy and chemotherapy have on the quality of life in women with breast cancer. Contrary to the commonly held view, 2 years after diagnosis, hormone therapy, a highly effective breast cancer treatment worsens quality of life to a greater extent and for a longer time, especially in menopausal patients.
Difficult to treat and aggressive "triple-negative" breast cancer is chemoresistant even before chemotherapy begins, a new study by researchers from Karolinska Institutet and the University of Texas MD Anderson Cancer Center reports. The findings, which are published in the journal Cell, may lead to better and more personalized treatments for breast cancer.
Researchers from Columbia University Medical Center, NewYork-Presbyterian, the Pediatric Cardiac Genetics Consortium, and the Pediatric Heart Network have found a number of genetic mutations that explain why many children with congenital heart disease also have other significant health challenges, including neurodevelopmental disorders and other congenital problems.
The AMA is co-sponsoring a symposium for CME credit this month in Tampa, Fla., on the medical and public health aspects of mercury exposure. "Mercury: Medical and Public Health Issues" will be held from April 28-30 at the Tampa Marriott Waterside Hotel and Marina.
Patients with the most common type of lung cancer are notoriously insensitive to chemotherapy drugs, including cisplatin. New findings related to the cellular pathways that regulate responses to cisplatin have now been published by Cell Press on July 26th in the journal Cell Reports.
› Verified 3 days ago
Georgianna M Richards, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 415 Carriage Dr, Beckley, WV 25801 Phone: 304-894-8975 | |
Johnny Dy, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 401 S Kanawha Street, Beckley, WV 25801 Phone: 304-252-0699 Fax: 304-255-6719 | |
Dr. Shilpa Sammeta, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 250 Stanaford Rd, Beckley, WV 25801 Phone: 304-254-2604 | |
John Henry Johnson Jr., MSW Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 24 Mallard Ct, Beckley, WV 25801 Phone: 304-252-8409 Fax: 304-252-0022 | |
Dr. Omar K Hasan, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 24 Mallard Ct, Beckley, WV 25801 Phone: 304-252-8409 Fax: 304-252-0022 | |
Hassan Arshad Jafary, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 250 Stanaford Rd, Suite 106, Beckley, WV 25801 Phone: 304-252-0786 | |
Dr. Barry K Vaught, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3155 Robert C Byrd Dr, Beckley, WV 25801 Phone: 304-252-4222 |